{"symbol": "MYGN", "companyName": "Myriad Genetics Inc.", "exchange": "Nasdaq Global Select", "industry": "Medical Diagnostics & Research", "website": "http://www.myriad.com", "description": "Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.", "CEO": "Mark Christopher Capone", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Diagnostics & Research", "Medical Diagnostics & Research"]}